Alternative Name: One-year LNG Single Rod Implant
Description: A single-rod one-year silastic implant containing 127 mg levonorgestrel (LNG).
Delivery Method: Subdermal
Duration Type: Long-acting
Duration: One year
Dose: 127 mg
Active Pharmaceutical Ingredient (API):
Inactive material: silastic
Multipurpose Preventive Technology (MPT): No
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Phase I
Active Development: No
- Phase I found lower serum LNG levels and less favorable bleeding patterns, so work discontinued.